Protein Expression Facility News Today

Share A global health organisation and state-of-the-art laboratory at The University of Queensland are collaborating to support the development and evaluation of point-of-care diagnostics for malaria with new custom-made proteins. PATH and UQ’s Protein Expression Facility will supply researchers with malaria proteins to improve point-of-care diagnostic tools and help reduce the burden of malaria, which continues to affect more than 200 million people and cause more than 400,000 deaths each...

Tuesday, 23 February 2021, 1:10 pm AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined forces with the University of Queensland in its vaccine production efforts. After halting development of its spike protein based candidate in December, CVC continues to progress development of its proprietary T-cell vaccine. Its T-cell vaccine is designed to work with other existing vaccines in order to improve efficacy, lengthen immunity time and to protect against all new variants for the SARS-Cov-2 vi...